Published 2012
| Version v1.0.0
Journal Article
Open
Fenfluramine Add-On Therapy of Dravet Syndrome
Creators
Abstract
Researchers at Antwerp University Hospital and University of Leuven, Belgium report 12 patients, 7 female and 5 male, age range 3-35 years, with a genetically proven diagnosis of Dravet syndrome who received fenfluramine (mean dose 0.34 (0.12-0.90) mg/kg/day) as add-on therapy.Files
PNB-2012-26-8-7.pdf
Files
(101.0 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:636745ae45d949f5d56b44ab1e52c3a3
|
101.0 kB | Preview Download |
Additional details
Identifiers
- Other
- PNB-2012-26-8-7
Dates
- Created
-
2012When the item was originally created.